Increased Serum Interleukin-34 Levels Are Related to the Presence and Severity of Cardiac Dysfunction in Patients With Ischemic Cardiomyopathy.
Increased Serum Interleukin-34 Levels Are Related to the Presence and Severity of Cardiac Dysfunction in Patients With Ischemic Cardiomyopathy.
复制标题
血清白细胞介素 34 水平升高与缺血性心肌病患者心脏功能障碍的存在及其严重程度相关
DOI:
10.3389/fphys.2018.00904
复制
发表时间:
2018
影响因子:
4
通讯作者:
Tao R
中科院分区:
文献类型:
--
作者:
Xi R;Fan Q;Yan X;Zhang H;Xie H;Gu G;Xu Y;Wang F;Tao R
Background: Several inflammatory factors have been demonstrated with diagnostic or prognostic value in patients with ischemic cardiomyopathy (ICM). Interleukin 34 (IL-34), an additional ligand of colony stimulating factor-1 receptor (CSF-1R), has been identified as a biomarker of coronary artery disease (CAD) and chronic kidney disease (CKD). However, the potential effect of IL-34 in ICM remains unknown. Methods: Serum IL-34 levels were detected in 360 subjects with ICM and in 465 subjects without ICM; the latter group included 233 controls without CAD and 232 patients with CAD and normal cardiac function. Uni- and multivariable logistic regression analyses were conducted to analyze the relationship between IL-34 and ICM. Results: IL-34 levels were significantly increased in patients with ICM compared with both groups of subjects without ICM (122.52 ± 115.30 vs. 95.02 ± 101.43 vs. 82.57 ± 84.24 pg/ml, respectively; P < 0.001). Moreover, serum IL-34 level was significantly positively correlated to NT-proBNP level (r = 0.223, P < 0.001), left ventricular end diastolic diameter and New York Heart Association (NYHA) functional class, indicating that a higher IL-34 level reflects more severe heart failure (HF). Multivariable regression analyses revealed that IL-34 was remarkably associated with the presence and severity of ICM after adjusting for age, sex, conventional risk factors as well as medication [odds ratio (OR): 1.501, 95% confidence interval (CI): 1.249–1.803, P < 0.001, per SD increase]. The predictive value of IL-34 value remained significant in patients already diagnosed with CAD. Conclusion: Increased IL-34 levels are relevant to the presence and severity of ischemic HF in all subjects and in patients with CAD. IL-34 may be used as a novel clinical biomarker of ICM with predictive value.
登录
查看更多内容
影响因子:
37.8
作者:
Robbins CS;Chudnovskiy A;Rauch PJ;Figueiredo JL;Iwamoto Y;Gorbatov R;Etzrodt M;Weber GF;Ueno T;van Rooijen N;Mulligan-Kehoe MJ;Libby P;Nahrendorf M;Pittet MJ;Weissleder R;Swirski FK
通讯作者:
Swirski FK
影响因子:
5.4
作者:
Tao R;Fan Q;Zhang H;Xie H;Lu L;Gu G;Wang F;Xi R;Hu J;Chen Q;Niu W;Shen W;Zhang R;Yan X
通讯作者:
Yan X
影响因子:
1.6
作者:
Li, Zhenglong;Jin, Daoqun;Chen, Zhiqiang
通讯作者:
Chen, Zhiqiang
影响因子:
13.5
作者:
Preisser, Laurence;Miot, Charline;Jeannin, Pascale
通讯作者:
Jeannin, Pascale
影响因子:
24
作者:
Bayes-Genis, Antoni;de Antonio, Marta;Lupon, Josep
通讯作者:
Lupon, Josep